These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 29701146)

  • 21. Melatonin: new places in therapy.
    Maharaj DS; Glass BD; Daya S
    Biosci Rep; 2007 Dec; 27(6):299-320. PubMed ID: 17828452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluating the Oxidative Stress in Inflammation: Role of Melatonin.
    Sánchez A; Calpena AC; Clares B
    Int J Mol Sci; 2015 Jul; 16(8):16981-7004. PubMed ID: 26225957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melatonin as a versatile molecule to design novel multitarget hybrids against neurodegeneration.
    Ramos E; Egea J; de Los Ríos C; Marco-Contelles J; Romero A
    Future Med Chem; 2017 May; 9(8):765-780. PubMed ID: 28498717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Melatonin as an Antiepileptic Molecule: Therapeutic Implications via Neuroprotective and Inflammatory Mechanisms.
    Akyuz E; Kullu I; Arulsamy A; Shaikh MF
    ACS Chem Neurosci; 2021 Apr; 12(8):1281-1292. PubMed ID: 33813829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Melatonin as an anti-inflammatory agent in radiotherapy.
    Najafi M; Shirazi A; Motevaseli E; Rezaeyan AH; Salajegheh A; Rezapoor S
    Inflammopharmacology; 2017 Aug; 25(4):403-413. PubMed ID: 28255737
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Melatonin for prevention of erythema and oxidative stress in response to ultraviolet radiation.
    Scheuer C
    Dan Med J; 2017 Jun; 64(6):. PubMed ID: 28566124
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin in diseases of the oral cavity.
    Gómez-Moreno G; Guardia J; Ferrera MJ; Cutando A; Reiter RJ
    Oral Dis; 2010 Apr; 16(3):242-7. PubMed ID: 19682319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Melatonin and Cancer: A Polyhedral Network Where the Source Matters.
    Bonmati-Carrion MA; Tomas-Loba A
    Antioxidants (Basel); 2021 Feb; 10(2):. PubMed ID: 33535472
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel therapeutic approaches in limiting oxidative stress and inflammation.
    Spychalowicz A; Wilk G; Śliwa T; Ludew D; Guzik TJ
    Curr Pharm Biotechnol; 2012 Oct; 13(13):2456-66. PubMed ID: 22280420
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Therapeutic effects of melatonin on endometriosis, targeting molecular pathways: Current knowledge and future perspective.
    Sharifi M; Rajabpoor Nikoo N; Badehnoosh B; Shafabakhsh R; Asemi R; Reiter RJ; Asemi Z
    Pathol Res Pract; 2023 Mar; 243():154368. PubMed ID: 36774757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relevance of the chronobiological and non-chronobiological actions of melatonin for enhancing therapeutic efficacy in neurodegenerative disorders.
    Cecon E; Markus RP
    Recent Pat Endocr Metab Immune Drug Discov; 2011 May; 5(2):91-9. PubMed ID: 22074584
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiinflammatory activity of melatonin in central nervous system.
    Esposito E; Cuzzocrea S
    Curr Neuropharmacol; 2010 Sep; 8(3):228-42. PubMed ID: 21358973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local melatonin regulates inflammation resolution: a common factor in neurodegenerative, psychiatric and systemic inflammatory disorders.
    Anderson G; Maes M
    CNS Neurol Disord Drug Targets; 2014; 13(5):817-27. PubMed ID: 25012620
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melatonin-Microbiome Two-Sided Interaction in Dysbiosis-Associated Conditions.
    Iesanu MI; Zahiu CDM; Dogaru IA; Chitimus DM; Pircalabioru GG; Voiculescu SE; Isac S; Galos F; Pavel B; O'Mahony SM; Zagrean AM
    Antioxidants (Basel); 2022 Nov; 11(11):. PubMed ID: 36421432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Visualization of melatonin's multiple mitochondrial levels of protection against mitochondrial Ca(2+)-mediated permeability transition and beyond in rat brain astrocytes.
    Jou MJ; Peng TI; Hsu LF; Jou SB; Reiter RJ; Yang CM; Chiao CC; Lin YF; Chen CC
    J Pineal Res; 2010 Jan; 48(1):20-38. PubMed ID: 19925580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.
    Halladin NL
    Dan Med J; 2015 Apr; 62(4):B5054. PubMed ID: 25872540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel synthetic derivative of melatonin, 5-hydroxy-2'-isobutyl-streptochlorin (HIS), inhibits inflammatory responses via regulation of TRIF-dependent signaling and inflammasome activation.
    Shim DW; Shin HJ; Han JW; Ji YE; Jang CH; Koppula S; Kang TB; Lee KH
    Toxicol Appl Pharmacol; 2015 Apr; 284(2):227-35. PubMed ID: 25689174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of in vitro tests for antioxidant and immunomodulatory capacities of compounds.
    Becker K; Schroecksnadel S; Gostner J; Zaknun C; Schennach H; Uberall F; Fuchs D
    Phytomedicine; 2014 Jan; 21(2):164-71. PubMed ID: 24041614
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melatonin.
    Hardeland R; Pandi-Perumal SR; Cardinali DP
    Int J Biochem Cell Biol; 2006 Mar; 38(3):313-6. PubMed ID: 16219483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Circadian rhythm and inflammatory bowel disease].
    Takagi T; Inada Y; Naito Y
    Nihon Rinsho; 2013 Dec; 71(12):2165-70. PubMed ID: 24437273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.